166 related articles for article (PubMed ID: 34355602)
1. Cytoreductive radical prostatectomy versus systemic therapy and radiation therapy in metastatic prostate cancer: A systematic review and meta-analysis.
Shemshaki H; Al-Mamari SA; Geelani IA; Kumar S
Urologia; 2022 Feb; 89(1):16-30. PubMed ID: 34355602
[TBL] [Abstract][Full Text] [Related]
2. Role of radical prostatectomy in metastatic prostate cancer: A review.
Metcalfe MJ; Smaldone MC; Lin DW; Aparicio AM; Chapin BF
Urol Oncol; 2017 Apr; 35(4):125-134. PubMed ID: 28190749
[TBL] [Abstract][Full Text] [Related]
3. Cytoreductive radical prostatectomy or radiation therapy for metastases prostate cancer: Evidence from meta-analysis.
Peng Z; Huang A
Medicine (Baltimore); 2022 Sep; 101(38):e30671. PubMed ID: 36197186
[TBL] [Abstract][Full Text] [Related]
4. The role of radical prostatectomy for the treatment of metastatic prostate cancer: a systematic review and meta-analysis.
Wang Y; Qin Z; Wang Y; Chen C; Wang Y; Meng X; Song N
Biosci Rep; 2018 Feb; 38(1):. PubMed ID: 29263146
[TBL] [Abstract][Full Text] [Related]
5. An Updated Systematic and Comprehensive Review of Cytoreductive Prostatectomy for Metastatic Prostate Cancer.
Yanagisawa T; Rajwa P; Kawada T; Bekku K; Laukhtina E; Deimling MV; Majdoub M; Chlosta M; Karakiewicz PI; Heidenreich A; Kimura T; Shariat SF
Curr Oncol; 2023 Feb; 30(2):2194-2216. PubMed ID: 36826131
[TBL] [Abstract][Full Text] [Related]
6. Cytoreductive prostatectomy: what is the evidence? A systematic review.
Albisinni S; Aoun F; Diamand R; Al-Hajj Obeid W; Porpiglia F; Roumeguère T; De Nunzio C
Minerva Urol Nefrol; 2019 Feb; 71(1):1-8. PubMed ID: 30547907
[TBL] [Abstract][Full Text] [Related]
7. Cytoreductive radical prostatectomy in metastatic prostate cancer: Does it really make sense?
Mathieu R; Korn SM; Bensalah K; Kramer G; Shariat SF
World J Urol; 2017 Apr; 35(4):567-577. PubMed ID: 27502935
[TBL] [Abstract][Full Text] [Related]
8. Cytoreductive Radical Prostatectomy in Men with Prostate Cancer and Skeletal Metastases.
Heidenreich A; Fossati N; Pfister D; Suardi N; Montorsi F; Shariat S; Grubmüller B; Gandaglia G; Briganti A; Karnes RJ
Eur Urol Oncol; 2018 May; 1(1):46-53. PubMed ID: 31100228
[TBL] [Abstract][Full Text] [Related]
9. The cytoreductive prostatectomy in metastatic prostate cancer: what the individual trials are hoping to answer.
Ranasinghe W; Chapin BF; Kim IY; Sooriakumaran P; Lawrentschuk N
BJU Int; 2020 Jun; 125(6):792-800. PubMed ID: 32176456
[TBL] [Abstract][Full Text] [Related]
10. Radical cytoreductive prostatectomy in men with prostate cancer and oligometastatic disease.
Heidenreich A; Pfister D
Curr Opin Urol; 2020 Jan; 30(1):90-97. PubMed ID: 31724996
[TBL] [Abstract][Full Text] [Related]
11. Cytoreductive prostatectomy in metastatic prostate cancer: a systematic review.
Becker JA; Berg KD; Røder MA; Brasso K; Iversen P
Scand J Urol; 2018 Feb; 52(1):1-7. PubMed ID: 28818014
[TBL] [Abstract][Full Text] [Related]
12. Multicentre, prospective study on local treatment of metastatic prostate cancer (LoMP study).
Buelens S; Poelaert F; Claeys T; De Bleser E; Dhondt B; Verla W; Ost P; Rappe B; De Troyer B; Verbaeys C; Kimpe B; Billiet I; Plancke H; Fransis K; Willemen P; Ameye F; Decaestecker K; Lumen N
BJU Int; 2022 Jun; 129(6):699-707. PubMed ID: 34289231
[TBL] [Abstract][Full Text] [Related]
13. Cytoreductive surgery in patients with oligometastatic prostate cancer. Systematic review of the scientific literature.
Ruiz Aragón J; Jiménez Varo E; Ruiz Aragón AI; Revelo Cadena I; Agüera Sánchez Á; Jiménez Romero ME
Actas Urol Esp (Engl Ed); 2023; 47(6):332-340. PubMed ID: 36319558
[TBL] [Abstract][Full Text] [Related]
14. Might definitive local therapy of the primary tumor improve the survival benefits of metastatic prostate cancer?-evidence from a meta-analysis.
Xiao M; Cong R; Zhang Q; Xiang W; Xiao H
Ann Palliat Med; 2020 May; 9(3):648-660. PubMed ID: 32312070
[TBL] [Abstract][Full Text] [Related]
15. The role of cytoreductive radical prostatectomy and lymph node dissection in bone-metastatic prostate cancer: A population-based study.
Zhai T; Ma J; Liu Y; Li H; Peng Y; Guo W; Jia J; Wu X; Jiang H; Tian J; Wang D
Cancer Med; 2023 Aug; 12(16):16697-16706. PubMed ID: 37366247
[TBL] [Abstract][Full Text] [Related]
16. Cytoreductive prostatectomy improves survival outcomes in patients with oligometastases: a systematic meta-analysis.
Mao Y; Hu M; Yang G; Gao E; Xu W
World J Surg Oncol; 2022 Aug; 20(1):255. PubMed ID: 35945562
[TBL] [Abstract][Full Text] [Related]
17. Cytoreductive radical prostatectomy in patients with prostate cancer and low volume skeletal metastases: results of a feasibility and case-control study.
Heidenreich A; Pfister D; Porres D
J Urol; 2015 Mar; 193(3):832-8. PubMed ID: 25254935
[TBL] [Abstract][Full Text] [Related]
18. Cytoreductive prostatectomy: evidence in support of a new surgical paradigm (Review).
Faiena I; Singer EA; Pumill C; Kim IY
Int J Oncol; 2014 Dec; 45(6):2193-8. PubMed ID: 25340386
[TBL] [Abstract][Full Text] [Related]
19. The Effect of Lymph Node Dissection in Metastatic Prostate Cancer Patients Treated with Radical Prostatectomy: A Contemporary Analysis of Survival and Early Postoperative Outcomes.
Mazzone E; Preisser F; Nazzani S; Tian Z; Bandini M; Gandaglia G; Fossati N; Montorsi F; Graefen M; Shariat SF; Saad F; Briganti A; Karakiewicz PI
Eur Urol Oncol; 2019 Sep; 2(5):541-548. PubMed ID: 31411992
[TBL] [Abstract][Full Text] [Related]
20. [Our experience with cytoreductive radical prostatectomy in patients with oligometastatic prostate cancer].
Berczi C; Dócs J; Flaskó T
Orv Hetil; 2021 Mar; 162(13):483-487. PubMed ID: 33774598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
